Concomitant chemoradiotherapy phase II study comparing pemetrexed/carboplatin with paclitaxel/carboplatin in patients with unresectable stage III non-small cell lung cancer.

Sheng Lin Ma,Yaping Xu,Y. Ji,Xiaojiang Sun,Yuanda Zheng

Concomitant chemoradiotherapy phase II study comparing pemetrexed/carboplatin with paclitaxel/carboplatin in patients with unresectable stage III non-small cell lung cancer.

2017

Sheng Lin Ma
Yaping Xu
Y. Ji
Xiaojiang Sun
Yuanda Zheng

e17527 Background: Concomitant chemoradiotherapy is the standard treatment of unresectable stage III non-small cell lung cancer (NSCLC). However, the optimal chemotherapy regimen is still controver...

Keywords:

Phases of clinical research
Pathology
Cell
Concomitant Chemoradiotherapy
Lung cancer
Oncology
Pemetrexed
Carboplatin
Standard treatment
Chemotherapy regimen
Medicine
Internal medicine
Paclitaxel carboplatin
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations